Receptors, neurotransmitters and drug responses.
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects; D001519:Behavior / Q000187:drug effects / Q000502:physiology; D001923:Brain Chemistry; D000242:Cyclic AMP / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D004745:Enkephalins / Q000378:metabolism; D006801:Humans; D006980:Hyperthyroidism / Q000378:metabolism; D008954:Models, Biological; D009121:Muscle Denervation; D009474:Neurons / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology*; D009638:Norepinephrine / Q000032:analysis; D010870:Pineal Gland / Q000502:physiology; D011433:Propranolol; D011941:Receptors, Adrenergic / Q000032:analysis / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects; D011978:Receptors, Nicotinic / Q000502:physiology; D011957:Receptors, Opioid / Q000032:analysis; D013375:Substance Withdrawal Syndrome / Q000378:metabolism; D019966:Substance-Related Disorders / Q000378:metabolism
D014150:Antipsychotic Agents; D004745:Enkephalins; D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D011978:Receptors, Nicotinic; D011957:Receptors, Opioid; D011433:Propranolol; D000242:Cyclic AMP; D009638:Norepinephrine